News 18 November 2026

Australia’s peak medical research body endorses puberty blockers as an option for trans youth

hands holding paper flag on transgender flag for trans healthcare

(Pixel-Shot/Shutterstock)

The National Health and Medical Research Council has advised that puberty blockers can be considered for some trans and gender-diverse young people, with treatment decisions to be made jointly by patients, families and clinicians.

Authored by
Sally Block

Puberty blockers have been provisionally backed by the nation’s peak medical research organisation. 

The federal government asked the National Health and Medical Research Council (NHMRC) to develop national guidelines and advice on puberty suppressants.

Interim guidelines have now been released.

The Federal Health Minister asked the NHMRC to create guidelines to provide the best care for highly vulnerable young Australians.

“I asked the NHMRC to publish advice on the use of puberty suppressants, ahead of finalisation of the full national guidelines,” the Minister for Health Mark Butler said.

“The NHMRC advice is puberty suppressants can be considered as a treatment option in the care of trans and gender diverse people aged under 18, however it is not a one-size-fits-all decision and may not be desired by, or appropriate for all young people accessing care.”

“This advice was developed in line with NHMRC guideline development processes and international best-practice methodology.”

“It is underpinned by a systematic review of the evidence and the expertise of clinicians, researchers and Australians with lived experience,” Minister Butler said.

What the NHMRC recommends

“A conditional recommendation for the use of puberty suppressants for young people aged under 18 with gender incongruence.  

As part of a shared decision between the young person, their parents or carers, and their clinicians, puberty suppressants can be considered for a young person who wants that care when the young person:

  • has commenced puberty;
  • has gender incongruence, with or without distress; and
  • is assessed as suitable for treatment in collaboration with clinicians.

A conditional recommendation recognises that treatment may be appropriate for some individuals but is not a one-size-fits-all decision. Shared decision-making involves young people, their parents or carers and clinicians discussing the available evidence, potential benefits and harms, and the young person’s individual circumstances and preferences before deciding together whether treatment is appropriate.”

States face pressure over existing bans

Currently states and territories are responsible for the provision of public gender services to young people.

Both Queensland and the Northern Territory have banned the prescribing of puberty blockers in the public system. 

Minister Butler urged them to consider the NHMRC interim guideline.

“State governments obviously have the ability to ensure the best possible care and support to all of their patients, including these young Australians.”

“I’m very confident that those state government services running these services will consider this advice very closely and make sure their services are aligning with it.”

Researchers welcome the interim advice

The advice has been welcomed by the Murdoch Children’s Research Institute (MCRI).

"The NHMRC’s advice highlights that puberty suppression remains an important, evidence-based part of person-centred care for trans young people in Australia,” said Dr Lou Kerley, who is the National program coordinator and Investigator for the Australian Research Consortium for Trans Youth and Children (ARCTYC) at the MCRI.

“It recognises that puberty suppression can be a helpful option for trans young people and supports shared decision-making between trans young people, their families, and gender-affirming clinicians,” Dr Kerley said.

“Importantly, the advice is consistent with current gender-affirming care in Australia and should provide reassurance to the community that clinicians have been providing safe and evidence-informed care.”

“The advice reflects the continued role of puberty suppression within established models of gender-affirming care for trans young people, while also highlighting that this care should be equitably available,” Dr Kerley said.

The final national guidelines are due to be released in late 2028.

Sally Block is the editor of the MJA’s InSight+. She is a former ABC Journalist.

Subscribe to the free InSight+ weekly newsletter here. It is available to all readers, not just registered medical practitioners.

Loading comments…

Newsletters

Subscribe to the InSight+ newsletter

Immediate and free access to the latest articles

No spam, you can unsubscribe anytime you want.

By providing your information, you agree to our Access Terms and our Privacy Policy. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.